CA2671799A1 - Cholesterylamines pour le traitement et la prevention de maladies infectieuses - Google Patents

Cholesterylamines pour le traitement et la prevention de maladies infectieuses Download PDF

Info

Publication number
CA2671799A1
CA2671799A1 CA002671799A CA2671799A CA2671799A1 CA 2671799 A1 CA2671799 A1 CA 2671799A1 CA 002671799 A CA002671799 A CA 002671799A CA 2671799 A CA2671799 A CA 2671799A CA 2671799 A1 CA2671799 A1 CA 2671799A1
Authority
CA
Canada
Prior art keywords
use according
virus
compound
spp
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002671799A
Other languages
English (en)
Inventor
Hans-Joachim Knolker
Sameer Agarwal
Georg Schlechtingen
Tobias Braxmeier
Cornelia Schroeder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technische Universitaet Dresden
Jado Technologies GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2671799A1 publication Critical patent/CA2671799A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002671799A 2006-12-08 2007-12-07 Cholesterylamines pour le traitement et la prevention de maladies infectieuses Abandoned CA2671799A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06025489 2006-12-08
EP06025489.3 2006-12-08
PCT/EP2007/010675 WO2008068037A1 (fr) 2006-12-08 2007-12-07 Cholestérylamines pour le traitement et la prévention de maladies infectieuses

Publications (1)

Publication Number Publication Date
CA2671799A1 true CA2671799A1 (fr) 2008-06-12

Family

ID=38985705

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002671799A Abandoned CA2671799A1 (fr) 2006-12-08 2007-12-07 Cholesterylamines pour le traitement et la prevention de maladies infectieuses

Country Status (6)

Country Link
EP (1) EP2097081A1 (fr)
JP (1) JP2010511648A (fr)
CN (1) CN101600429A (fr)
AU (1) AU2007327761A1 (fr)
CA (1) CA2671799A1 (fr)
WO (1) WO2008068037A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010045199A2 (fr) * 2008-10-13 2010-04-22 University Of South Florida Méthode de modulation de l'activité de ship
WO2010105910A1 (fr) * 2009-03-19 2010-09-23 Seps Pharma N.V. Dérivés de fosfluconazole, synthèse, et utilisation dans des formulations à longue durée d'action
WO2011127465A2 (fr) * 2010-04-09 2011-10-13 The Research Foundation Of The State University Of New York Inhibiteurs de ship et leurs utilisations
FR2967914A1 (fr) * 2010-11-29 2012-06-01 Centre Nat Rech Scient Composes inhibiteurs d'interactions proteine-proteine ciblant les proteines kinases et leurs applications biologiques
CA2953917C (fr) * 2013-07-01 2021-10-19 The Research Foundation For The State University Of New York Inhibition de ship dans le cadre de la lutte contre l'obesite
CN105037471B (zh) * 2014-05-02 2018-03-23 扬州蓝色生物医药科技有限公司 一种甾体类抗病毒剂
EP3157529B1 (fr) 2014-06-17 2021-08-04 The Research Foundation for The State University of New York Inhibition de ship pour l'induction de l'activation de cellules tueuses naturelles
WO2017223320A1 (fr) * 2016-06-22 2017-12-28 University Of Maryland, Baltimore Procédé de production de nouveaux analogues de galétérone et leurs utilisations
CN108467423B (zh) * 2018-05-14 2020-06-30 四川师范大学 一类新型分枝杆菌抑制剂的合成方法及用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB519468A (en) * 1937-10-16 1940-03-28 Organon Nv Process for preparing steroid-like derivatives and products obtained thereby
US2227876A (en) * 1937-10-16 1941-01-07 Firm Of N V Organon Steroid derivatives with nuclear substituted nitrogen
AT308982B (de) * 1970-06-18 1973-07-25 Richter Gedeon Vegyeszet Verfahren zur Herstellung von 2- und 3-Aza-Cholestanderivaten
SU1072447A1 (ru) * 1982-07-19 1989-08-30 Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Им.С.Орджоникидзе А-Нор-3-аза-хлорацетил-5 @ -холестан, обладающий противоопухолевой активностью
CA1252778A (fr) * 1983-08-25 1989-04-18 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Steroides
WO1994020520A1 (fr) * 1993-03-10 1994-09-15 Magainin Pharmaceuticals Inc. Derives steroidiens, compositions pharmaceutiques contenant ces derives steroidiens et utilisation de ces derniers comme antibiotiques ou desinfectants
US6388108B1 (en) * 1998-08-12 2002-05-14 Genaera Corporation Aminosterol compounds and uses thereof
AU2005259499A1 (en) * 2004-06-29 2006-01-12 Jado Technologies Gmbh Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts
JP5232009B2 (ja) * 2005-12-19 2013-07-10 エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング 低減された細胞毒性を有するアルキルリン脂質誘導体並びにそれらの使用

Also Published As

Publication number Publication date
CN101600429A (zh) 2009-12-09
AU2007327761A1 (en) 2008-06-12
JP2010511648A (ja) 2010-04-15
EP2097081A1 (fr) 2009-09-09
WO2008068037A1 (fr) 2008-06-12

Similar Documents

Publication Publication Date Title
CA2671799A1 (fr) Cholesterylamines pour le traitement et la prevention de maladies infectieuses
WO2009090063A1 (fr) Dérivés de sapogénine stéroïde, androstane et sapogénine triterpénoïde pour le traitement et la prévention de maladies infectieuses
CN105189468B (zh) 用于治疗病毒性感染的2-氨基嘧啶衍生物
CA3019630A1 (fr) Amides heterocycliques utiles en tant que modulateurs de proteine
JP2017206528A (ja) 抗ウイルス処置のための２’−置換カルバヌクレオシド類似体
CA3135802A1 (fr) Agents de degradation de stat et leurs utilisations
EP2625190A2 (fr) Dérivés de benzylamines stéroïdes à action antiparasitaire, antibactérienne, antifongique et/ou antivirale
MX2014007280A (es) Derivados de betulina.
AU2013225633B2 (en) Ingenol derivatives in the reactivation of latent HIV
TW201113279A (en) Pharmaceutical compositions useful for treating HCV
JP2017521424A (ja) ウイルス疾患の治療、改善又は予防におけるジヒドロピリドピラジン−１，８−ジオン及びそれらの使用
CA2571440A1 (fr) Utilisation de compositions pharmaceutiques derivees de steroides pour le traitement de troubles associes a des processus pathologiques dans les radeaux lipidiques
CA3022119A1 (fr) Compositions therapeutiques a base de nucleotides et nucleosides contenant un alcyne et utilisations associees
CA3150316A1 (fr) Agents de degradation de l'erk5 utilises comme agents therapeutiques dans le cancer et les maladies inflammatoires
CA3204255A1 (fr) Polytherapie contre le vih comprenant un derive d'adenosine et des inhibiteurs de capside
CN111315383B (zh) 共享表位-钙网蛋白相互作用的小分子抑制剂和使用方法
EP2847201B1 (fr) Inhibiteurs de 6-oxopurine phosphoribosyltransférase
JP2000247993A (ja) トリテルペノイド系化合物を含んでなるσレセプター作用薬
WO2003068736A2 (fr) Composes melanges de steroides 1,2,4,5-tetraoxane et procedes de fabrication associes
CN112724156B (zh) 一种多环吡啶酮衍生物和药物组合物及其应用
WO2008059800A1 (fr) Nouveaux dérivés de polyamine
CN108707173A (zh) 作为fxr调节剂的阿维菌素衍生物
TWI821343B (zh) 流感病毒複製之抑制劑
CN104844679A (zh) 白桦脂醇的衍生物
US11919895B2 (en) GPR183 antagonists for the treatment of pain

Legal Events

Date Code Title Description
FZDE Dead